Drugs / FK50
last change Nov 2004 re-read 2 minutes ago

FK50

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00048412 Background Jun 2000 → Nov 2004 leukemia, lymphoproliferative syndrome, myelodysplastic syndrome, plasma cell myeloma Baylor College of Medicine Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FK50 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00048412